Lisa S. Chen

1.2k total citations
32 papers, 911 citations indexed

About

Lisa S. Chen is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Lisa S. Chen has authored 32 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 14 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Lisa S. Chen's work include Cancer Mechanisms and Therapy (11 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Multiple Myeloma Research and Treatments (5 papers). Lisa S. Chen is often cited by papers focused on Cancer Mechanisms and Therapy (11 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Multiple Myeloma Research and Treatments (5 papers). Lisa S. Chen collaborates with scholars based in United States, United Kingdom and Finland. Lisa S. Chen's co-authors include Varsha Gandhi, Sanjeev Redkar, William G. Wierda, Jörge E. Cortes, Christine M. Stellrecht, David J. Bearss, Pietro Taverna, Kumudha Balakrishnan, Sattva S. Neelapu and Qingshan Yang and has published in prestigious journals such as Blood, Cancer and Cancer Research.

In The Last Decade

Lisa S. Chen

31 papers receiving 880 citations

Peers

Countries citing papers authored by Lisa S. Chen

Since Specialization

Citations

This map shows the geographic impact of Lisa S. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa S. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa S. Chen more than expected).

Fields of papers citing papers by Lisa S. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa S. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa S. Chen. The network helps show where Lisa S. Chen may publish in the future.

Co-authorship network of co-authors of Lisa S. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa S. Chen. A scholar is included among the top collaborators of Lisa S. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa S. Chen. Lisa S. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 1 trial of 8‐chloro‐adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics 2023 ·Cancer ·Vinod Pullarkat, Lisa S. Chen, Joycelynne Palmer, Jianying Zhang, Timothy W. Synold, Ralf Buettner, Le Xuan Truong Nguyen, Guido Marcucci, Ni‐Chun Tsai, (unknown), (unknown), Varsha Gandhi, Steven T. Rosen	2
2	Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia 2022 ·Blood Cancer Journal ·Burcu Aslan, Görkem Kısmalı, (unknown), Ganiraju C. Manyam, Mary Ayres, Lisa S. Chen, Mihai Gagea, Maria Teresa Sabrina Bertilaccio, William G. Wierda, Varsha Gandhi	33
3	Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine 2021 ·Journal of Hematology & Oncology ·Ralf Buettner, Le Xuan Truong Nguyen, (unknown), (unknown), Xiwei Wu, Lisa S. Chen, (unknown), (unknown), Vinod Pullarkat, Varsha Gandhi, Guido Marcucci, Steven T. Rosen	41
4	The Right Dose: From Phase I to Clinical Practice 2021 ·American Society of Clinical Oncology Educational Book ·Stefanie L. Groenland, Mark J. Ratain, Lisa S. Chen, Varsha Gandhi	9
5	Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers 2018 ·British Journal of Cancer ·Jörge E. Cortes, Kenji Tamura, Daniel J. DeAngelo, Johann S. de Bono, David Lorente, Mark D. Minden, Geoffrey L. Uy, Hagop M. Kantarjian, Lisa S. Chen, Varsha Gandhi, Robert Godin, Karen Keating, Kristen McEachern, Karthick Vishwanathan, J. Elizabeth Pease, Emma Dean	83
6	Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma 2016 ·Clinical Cancer Research ·Qingshan Yang, Lisa S. Chen, Min Jin Ha, Kim‐Anh Do, Sattva S. Neelapu, Varsha Gandhi	10
7	Protein profiling identifies mTOR pathway modulation and cytostatic effects of Pim kinase inhibitor, AZD1208, in acute myeloid leukemia 2016 ·Leukemia & lymphoma ·Lisa S. Chen, Ji-Yeon Yang, Liang Han, Jörge E. Cortes, Varsha Gandhi	17
8	Abstract 4529: The PI3Kδ inhibitor, idelalisib, inhibits transcription and translation through PI3K/Akt pathway in mantle cell lymphoma 2014 ·Cancer Research ·Qingshan Yang, Lisa S. Chen, Sattva S. Neelapu, Varsha Gandhi	2
9	Combination of Pim Kinase Inhibitor SGI-1776 and Bendamustine in B-Cell Lymphoma 2013 ·Clinical Lymphoma Myeloma & Leukemia ·Qingshan Yang, Lisa S. Chen, Sattva S. Neelapu, Varsha Gandhi	11
10	Biological Effects of the Pim Kinase Inhibitor, SGI-1776, in Multiple Myeloma 2013 ·Clinical Lymphoma Myeloma & Leukemia ·Fabiola Cervantes-Gomez, Lisa S. Chen, Robert Z. Orlowski, Varsha Gandhi	44
11	Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia 2013 ·Leukemia & lymphoma ·Viralkumar Patel, Lisa S. Chen, William G. Wierda, Kumudha Balakrishnan, Varsha Gandhi	20
12	Multifaceted actions of 8-amino-adenosine kill BCR–ABL positive cells 2012 ·Leukemia & lymphoma ·Rathi N. Pillai, Lisa S. Chen, Mary Ayres, Billie Nowak, Michael W. Thomas, Elizabeth J. Shpall, Michael J. Keating, Varsha Gandhi	2
13	Transcription Inhibition as a Therapeutic Target for Cancer 2011 ·Cancers ·Christine M. Stellrecht, Lisa S. Chen	25
14	Inflammation and survival pathways: Chronic lymphocytic leukemia as a model system 2010 ·Biochemical Pharmacology ·Lisa S. Chen, Kumudha Balakrishnan, Varsha Gandhi	43
15	Inhibition of ATP synthase by chlorinated adenosine analogue 2009 ·Biochemical Pharmacology ·Lisa S. Chen, Billie Nowak, Mary Ayres, Nancy Krett, Steven T. Rosen, Shuxing Zhang, Varsha Gandhi	27
16	Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues 2009 ·Biochemical Pharmacology ·Lisa S. Chen, Lei Du‐Cuny, Vasupradha Vethantham, David H. Hawke, James L. Manley, Shuxing Zhang, Varsha Gandhi	14
17	Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues 2008 ·Leukemia Research ·Lisa S. Chen, William Plunkett, Varsha Gandhi	14
18	Pim Kinase Inhibitor, SGI-1776, Induces Apoptosis in CLL Lymphocytes 2008 ·Blood ·Lisa S. Chen, William G. Wierda, Sanjeev Redkar, David J. Bearss, Varsha Gandhi	3
19	RNA‐directed agent, cordycepin, induces cell death in multiple myeloma cells 2008 ·British Journal of Haematology ·Lisa S. Chen, Christine M. Stellrecht, Varsha Gandhi	59
20	Second-Parent Adoptions: Are They Entitled to Full Faith and Credit 2005 ·eYLS (Yale Law School) ·Lisa S. Chen	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact